Corymbosin

Corymbosin

SCHEMBL1421623

COc1cc(O)c2c(=O)cc(-c3cc(OC)c(OC)c(OC)c3)oc2c1.COc1cc(O)c2c(=O)cc(-c3cc(OC)c(OC)cc3OC)oc2c1.COc1cc(O)c2c(=O)cc(-c3ccc(OCc4ccccc4)c(OC)c3)oc2c1.COc1ccc(-c2cc(=O)c3c(O)cc(OC)cc3o2)cc1

nearest known ligand 0.56

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAOB P27338 2/20 0.56
▸ CYP19A1 P11511 1/20 0.56
▸ MAPT P10636 3/20 0.55
▸ ABCB1 P08183 2/20 0.55
▸ NPC1 O15118 2/20 0.55
▸ CYP3A4 P08684 2/20 0.55
▸ CYP2C9 P11712 2/20 0.55
▸ CYP2C19 P33261 2/20 0.55
▸ TSHR P16473 1/20 0.55
▸ ABCG2 Q9UNQ0 1/20 0.55
▸ BCL2 P10415 1/20 0.53
▸ BCL2L1 Q07817 1/20 0.53
▸ CYP1B1 Q16678 3/20 0.52
▸ FLT3 P36888 3/20 0.52
▸ IP6K2 Q9UHH9 2/20 0.52
▸ CDK8 P49336 2/20 0.52
▸ MEN1 O00255 2/20 0.52
▸ ALDH1A1 P00352 2/20 0.52
▸ KMT2A Q03164 2/20 0.52
▸ CYP1A1 P04798 2/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1423904 0.90 MEN1 (0.52) ABCB1ABCG2CYP1B1FLT3MEN1
SCHEMBL1976256 0.88 MAPT (0.67) MAOBCYP19A1MAPTABCB1NPC1
SCHEMBL24514602 0.81 CYP1A1 (0.75) MAPTABCB1ABCG2CYP1B1FLT3
SCHEMBL1421600 0.81 ABCG2 (0.67) MAPTABCB1NPC1CYP3A4CYP2C9
SCHEMBL24514601 0.81 ABCB1 (0.73) ABCB1ABCG2CYP1B1MEN1ALDH1A1
SCHEMBL1421607 0.80 FLT3 (0.56) MAOBCYP19A1MAPTABCB1NPC1
SCHEMBL24514598 0.80 ABCB1 (0.68) ABCB1ABCG2CYP1B1MEN1ALDH1A1
SCHEMBL7156543 0.79 ABCB1 (0.69) ABCB1ABCG2CYP1B1MEN1ALDH1A1
SCHEMBL7306849 0.78 MAPT (0.74) MAOBCYP19A1MAPTABCB1NPC1
SCHEMBL8062100 0.78 MEN1 (0.71) MAPTABCB1ABCG2FLT3MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2297127-A1 CHROMENONE DERIVATIVES USEFUL FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES AxoGlia Therapeutics S.A. (LU) 2011-03-23 — — EP disclosed
WO-2009130253-A1 CHROMENONE DERIVATIVES USEFUL FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES AXOGLIA THERAPEUTICS S.A. (LU) 2009-10-29 — — WO disclosed
Send feedback